References
- Yip CC, Lau SK, Woo PC, et al. Human enterovirus 71 epidemics: what’s next? Emerg Health Threats J. 2013;6:19780.
- Zhao Q, Xiong Y, Xu J, et al. Host microRNA hsa-miR-494-3p promotes EV71 replication by directly targeting PTEN. Front Cell Infect Microbiol. 2018;8:278.
- Chan LG, Parashar UD, Lye MS, et al. Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clinl Infect Dis. 2000;31:678–683.
- Stifter SA, Feng CG. Interfering with immunity: detrimental role of type I IFNs during infection. J Iimmunol. 2015;194:2455–2465.
- Killip MJ, Fodor E, Randall RE. Influenza virus activation of the interferon system. Virus Res. 2015;209:11–22.
- Hoffmann HH, Schneider WM, Rice CM. Interferons and viruses: an evolutionary arms race of molecular interactions. Trends Immunol. 2015;36:124–138.
- Chen W, Han C, Xie B, et al. Induction of siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation. Cell. 2013;152:467–478.
- Fu Y, Zhang L, Zhang F, et al. Exosome-mediated miR-146a transfer suppresses type I interferon response and facilitates EV71 infection. PLoS Pathog. 2017;13:e1006611.
- Zheng C, Zheng Z, Sun J, et al. MiR-16-5p mediates a positive feedback loop in EV71-induced apoptosis and suppresses virus replication. Sci Rep. 2017;7:16422.
- Honda K, Yanai H, Negishi H, et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature. 2005;434:772–777.
- Sato M, Suemori H, Hata N, et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity. 2000;13:539–548.
- He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5:522–531.
- Yao L, Wu CX, Zheng K, et al. Immunogenic response to a recombinant pseudorabies virus carrying bp26 gene of Brucella melitensis in mice. Res Vet Sci. 2015;100:61–67.
- Chen L, Song Y, He L, et al. MicroRNA-223 promotes type I interferon production in antiviral innate immunity by Targeting forkhead box protein O3 (FOXO3). J Biol Chem. 2016;291:14706–14716.
- Ma Y, Wang C, Xue M, et al. The coronavirus transmissible gastroenteritis virus evades the type I interferon response through IRE1alpha-mediated manipulation of the microRNA miR-30a-5p/SOCS1/3 axis. J Virol. 2018;92:e00728-18.
- Xie Y, He S, Wang J. MicroRNA-373 facilitates HSV-1 replication through suppression of type I IFN response by targeting IRF1. Biomed Pharmacothe. 2018;97:1409–1416.
- Feng N, Zhou Z, Li Y, et al. Enterovirus 71-induced has-miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1. Virus Res. 2017;237:27–36.
- Stanic M. A simplification of the estimation of the 50 percent endpoints according to the Reed and Muench method. Pathologia et microbiologia. 1963;26:298–302.
- Mei LL, Wang WJ, Qiu YT, et al. miR-125b-5p functions as a tumor suppressor gene partially by regulating HMGA2 in esophageal squamous cell carcinoma. PloS One. 2017;12:e0185636.
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–408.
- Ren L, Zhao Y, Huo X, et al. MiR-155-5p promotes fibroblast cell proliferation and inhibits FOXO signaling pathway in vulvar lichen sclerosis by targeting FOXO3 and CDKN1B. Gene. 2018;653:43–50.
- Wu H, Huang T, Ying L, et al. MiR-155 is involved in renal ischemia-reperfusion injury via direct targeting of FoxO3a and regulating renal tubular cell pyroptosis. Cell Physiol Biochem. 2016;40:1692–1705.
- Li B, Zheng J. MicroR-9-5p suppresses EV71 replication through targeting NFkappaB of the RIG-I-mediated innate immune response. FEBS Open Bio. 2018;8:1457–1470.
- Wang YF, Chou CT, Lei HY, et al. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol. 2004;78:7916–7924.
- Ho BC, Yu IS, Lu LF, et al. Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type I interferon. Nat Commun. 2014;5:3344.
- Bao JL, Lin L. MiR-155 and miR-148a reduce cardiac injury by inhibiting NF-kappaB pathway during acute viral myocarditis. Eur Rev Med Pharmacol Sci. 2014;18:2349–2356.
- Pareek S, Roy S, Kumari B, et al. MiR-155 induction in microglial cells suppresses Japanese encephalitis virus replication and negatively modulates innate immune responses. J Neuroinflammation. 2014;11:97.
- Xie C, Ren GL, Xu MC, et al. The effect of miR-155 on HBV replication and PTEN expression in vivo. Zhonghua Gan Zang Bing Za Zhi. 2018;26:489–494.
- Wang B, Fu M, Liu Y, et al. gga-miR-155 enhances type I interferon expression and suppresses infectious burse disease virus replication via targeting SOCS1 and TANK. Front Cell Infect Microbiol. 2018;8:55.
- Gupta R, Arkatkar T, Keck J, et al. Antigen specific immune response in Chlamydia muridarum genital infection is dependent on murine microRNAs-155 and −182. Oncotarget. 2016;7:64726–64742.
- Cordey S, Petty TJ, Schibler M, et al. Identification of site-specific adaptations conferring increased neural cell tropism during human enterovirus 71 infection. PLoS Pathog. 2012;8:e1002826.
- Strauss M, Filman DJ, Belnap DM, et al. Nectin-like interactions between poliovirus and its receptor trigger conformational changes associated with cell entry. J Virol. 2015;89:4143–4157.
- Rasti M, Khanbabaei H, Teimoori A. An update on enterovirus 71 infection and interferon type I response. Rev Med Virol. 2019;29:e2016.
- Huang J, Jiao J, Xu W, et al. MiR-155 is upregulated in patients with active tuberculosis and inhibits apoptosis of monocytes by targeting FOXO3. Mol Med Rep. 2015;12:7102–7108.
- Gao Y, Liu Z, Ding Z, et al. MicroRNA-155 increases colon cancer chemoresistance to cisplatin by targeting forkhead box O3. Oncol Lett. 2018;15:4781–4788.
- Litvak V, Ratushny AV, Lampano AE, et al. A FOXO3-IRF7 gene regulatory circuit limits inflammatory sequelae of antiviral responses. Nature. 2012;490:421–425.
- He X, Teng J, Cui C, et al. MicroRNA-182 inhibits HCMV replication through activation of type I IFN response by targeting FOXO3 in neural cells. Exp Cell Res. 2018;369:197–207.
- Chang LY, Huang LM, Gau SS, et al. Neurodevelopment and cognition in children after enterovirus 71 infection. N Engl J Med. 2007;356:1226–1234.
- Huang CC, Liu CC, Chang YC, et al. Neurologic complications in children with enterovirus 71 infection. N Engl J Med. 1999;341:936–942.
- Bochnakian A, Zhen A, Zisoulis DG, et al. Interferon-inducible miR-128 modulates HIV-1 replication by targeting TNPO3 mRNA. J Virol. 2019;93:e00364-19.
- Zhang X, Guo Y, Xu X, et al. miR-146a promotes Borna disease virus 1 replication through IRAK1/TRAF6/NF-kappaB signaling pathway. Virus Res. 2019;271:197671.
- Wang K, Lai C, Gu H, et al. miR-194 inhibits innate antiviral immunity by targeting FGF2 in influenza H1N1 virus infection. Front Microbiol. 2017;8:2187.
- Sun Y, Feng L, Li J, et al. miR-545 promoted enterovirus 71 replication via directly targeting phosphatase and tensin homolog and tumor necrosis factor receptor-associated factor 6. J Cell Physiol. 2019;234:15686–15697.
- Wen BP, Dai HJ, Yang YH, et al. MicroRNA-23b inhibits enterovirus 71 replication through downregulation of EV71 VPl protein. Intervirology. 2013;56:195–200.
- Sadler AJ, Williams BR. Interferon-inducible antiviral effectors. Nat Rev Immunol. 2008;8:559–568.
- Schoggins JW, Rice CM. Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol. 2011;1:519–525.
- Zhai T, Wu C, Wang N, et al. Development of a monoclonal antibody against swine leukocyte antigen (SLA)-DR alpha chain and evaluation of SLA-DR expression in bone marrow-derived dendritic cells after PRRSV infection. Vet Immunol Immunopathol. 2019;211:19–24.
- Wang P, Hou J, Lin L, et al. Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. J Iimmunol. 2010;185:6226–6233.
- Liu X, Cai X, Zhang D, et al. Zebrafish foxo3b negatively regulates antiviral response through suppressing the transactivity of irf3 and irf7. J Iimmunol. 2016;197:4736–4749.